Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

IMPORTANCE: Immune checkpoint inhibitors (ICIs) are increasingly used in patients with advanced hepatocellular carcinoma (HCC). However, data on ICI therapy in patients with advanced HCC and impaired liver function are scarce. OBJECTIVE: To conduct a systematic review and meta-analysis to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Enrui, Yeo, Yee Hui, Scheiner, Bernhard, Zhang, Yue, Hiraoka, Atsushi, Tantai, Xinxing, Fessas, Petros, de Castro, Tiago, D’Alessio, Antonio, Fulgenzi, Claudia Angela Maria, Xu, Shuo, Tsai, Hong-Ming, Kambhampati, Swetha, Wang, Wenjun, Keenan, Bridget P., Gao, Xu, Xing, Zixuan, Pinter, Matthias, Lin, Yih-Jyh, Guo, Zhanjun, Vogel, Arndt, Tanaka, Takaaki, Kuo, Hsin-Yu, Kelley, Robin K., Kudo, Masatoshi, Yang, Ju Dong, Pinato, David J., Ji, Fanpu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450588/
https://www.ncbi.nlm.nih.gov/pubmed/37615958
http://dx.doi.org/10.1001/jamaoncol.2023.3284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450588/
https://www.ncbi.nlm.nih.gov/pubmed/37615958
http://dx.doi.org/10.1001/jamaoncol.2023.3284

Ejemplares similares